Literature DB >> 27196970

A Central Move for CB2 Receptors.

Salma A Quraishi1, Carlos A Paladini2.   

Abstract

The function of the CB2 cannabinoid receptor in the brain has long been a matter of debate. In this issue of Neuron, Stempel et al. (2016) describe a mechanism whereby endocannabinoid production leads to a cell-intrinsic hyperpolarization that controls self activity.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27196970     DOI： 10.1016/j.neuron.2016.05.012

Source DB:  PubMed          Journal:  Neuron        ISSN： 0896-6273            Impact factor:   17.173


  8 in total

1.  Endocannabinoids exert CB1 receptor-mediated neuroprotective effects in models of neuronal damage induced by HIV-1 Tat protein.

Authors:  Changqing Xu; Douglas J Hermes; Blessing Nwanguma; Ian R Jacobs; Kenneth Mackie; Somnath Mukhopadhyay; Aron H Lichtman; Bogna Ignatowska-Jankowska; Sylvia Fitting
Journal:  Mol Cell Neurosci       Date:  2017-07-19       Impact factor: 4.314

2.  Preliminary in vivo evidence of lower hippocampal synaptic density in cannabis use disorder.

Authors:  Deepak Cyril D'Souza; Rajiv Radhakrishnan; Mika Naganawa; Suhas Ganesh; Nabeel Nabulsi; Soheila Najafzadeh; Jim Ropchan; Mohini Ranganathan; Jose Cortes-Briones; Yiyun Huang; Richard E Carson; Patrick Skosnik
Journal:  Mol Psychiatry       Date:  2020-09-24       Impact factor: 15.992

Review 3.  Modulation of Endocannabinoid System Components in Depression: Pre-Clinical and Clinical Evidence.

Authors:  Uri Bright; Irit Akirav
Journal:  Int J Mol Sci       Date:  2022-05-15       Impact factor: 6.208

Review 4.  Integrating endocannabinoid signaling in the regulation of anxiety and depression.

Authors:  An-Qi Yin; Feng Wang; Xia Zhang
Journal:  Acta Pharmacol Sin       Date:  2018-07-12       Impact factor: 6.150

5.  Cannabinoid Receptors and Ligands: Lessons from CNS Disorders and the Quest for Novel Treatment Venues.

Authors:  Clara M Vecchini Rodríguez; Yma Escalona Meléndez; Jacqueline Flores-Otero
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

6.  Cannabinoid receptor CB2 ablation protects against TAU induced neurodegeneration.

Authors:  M Galán-Ganga; C Rodríguez-Cueto; J Merchán-Rubira; F Hernández; J Ávila; M Posada-Ayala; J L Lanciego; E Luengo; M G Lopez; A Rábano; J Fernández-Ruiz; I Lastres-Becker
Journal:  Acta Neuropathol Commun       Date:  2021-05-17       Impact factor: 7.801

7.  Cannabinoid type 2 receptors in dopamine neurons inhibits psychomotor behaviors, alters anxiety, depression and alcohol preference.

Authors:  Qing-Rong Liu; Ana Canseco-Alba; Hai-Ying Zhang; Patricia Tagliaferro; Monika Chung; Eugene Dennis; Branden Sanabria; Norman Schanz; Joao Carlos Escosteguy-Neto; Hiroki Ishiguro; Zhicheng Lin; Susan Sgro; Claire M Leonard; Jair Guilherme Santos-Junior; Eliot L Gardner; Josephine M Egan; Jeung Woon Lee; Zheng-Xiong Xi; Emmanuel S Onaivi
Journal:  Sci Rep       Date:  2017-12-12       Impact factor: 4.379

8.  Protective role of neuronal and lymphoid cannabinoid CB2 receptors in neuropathic pain.

Authors:  David Cabañero; Angela Ramírez-López; Eva Drews; Anne Schmöle; David M Otte; Agnieszka Wawrzczak-Bargiela; Hector Huerga Encabo; Sami Kummer; Antonio Ferrer-Montiel; Ryszard Przewlocki; Andreas Zimmer; Rafael Maldonado
Journal:  Elife       Date:  2020-07-20       Impact factor: 8.140
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.